Changes in body weight and blood pressure among women using Depo-Provera injection in Northwest Ethiopia

Autor:	Tabarak Malik, Yohannes Mulu Ferede, Tesfahun Bekele, Yigizie Yeshaw, Muluken Fekadie Zerihun
Jazyk:	angličtina
Rok vydání:	2019
Předmět:	Adult 0301 basic medicine medicine.medical_specialty lcsh:Medicine Medroxyprogesterone Acetate Depo Provera Weight Gain General Biochemistry Genetics and Molecular Biology Body Mass Index Injections Young Adult 03 medical and health sciences 0302 clinical medicine Bone Density Contraceptive Agents Female medicine Humans Medroxyprogesterone acetate 030212 general & internal medicine Adverse effect lcsh:Science (General) lcsh:QH301-705.5 Bone mineral Obstetrics business.industry lcsh:R General Medicine Body weight Menstruation Research Note Cross-Sectional Studies 030104 developmental biology Blood pressure lcsh:Biology (General) Female Analysis of variance Ethiopia medicine.symptom business Body mass index Weight gain Student's t-test medicine.drug lcsh:Q1-390
Zdroj:	BMC Research Notes, Vol 12, Iss 1, Pp 1-5 (2019) BMC Research Notes
ISSN:	1756-0500
Popis:	Objectives: Depo-Provera is an injectable contraceptive method containing medroxyprogesterone acetate. It has some adverse effects like changes in menstrual pattern, loss in bone mineral density and risk of weight gain. Therefore, this study is aimed at to investigate the effects of Depo-Provera on body weight and blood pressure among Ethiopian women. Institution based cross-sectional study design was conducted from January 2017 to April 2017. Data were analyzed using SPSS version 21 software. Paired t-test, independent t-test and ANOVA were used to evaluate the presence of mean difference and relationship between changes in variables and duration of use of Depo-Provera. P-value ≤ 0.05 were considered as statistically significant. Results: The mean weight and body mass index (BMI) of Depo-Provera users were increased significantly (p=0.02 for mean body weight and p=0.019, for body mass index). There was no significant difference in mean arterial blood pressure (MAP) of Depo-Provera users compared to controls or their respective pretreatment value (p-value=0.85 for Depo-Provera users and 0.67 for non-users). The finding of this study revealed that there is an increased weight gain and BMI among Depo-Provera users compared to non-users, which really requires attention of health professionals and other stake holders.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21d66c21c44bcc2131799b82bf06d3d2 http://link.springer.com/article/10.1186/s13104-019-4555-y Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.